GGrantIndex
← Leaderboards

Peter J Mohler

Ohio State University

Google Scholar ↗PubMed ↗ORCID ↗
$16,792,878
Attributed
$20,923,422
Total exposure
8
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2M · FY2006–23
$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$20,923,422 · 8

By mechanism

R01$12,264,497 · 4
R35$5,971,888 · 1
T32$1,803,128 · 1
R44$863,909 · 1
R13$20,000 · 1

Top collaborators

Most similar at Ohio State University

Same institution · by research overlap

Others in their field

Top investigators on “Heart”

Research focus

HeartArrhythmiaCardiacHeart DiseasesPathway InteractionsProteinsMembraneFunctional DisorderMolecularBaseAnkyrinsCellsPlayVentricularInnovationIon ChannelDefectIn VivoRegulationComplexCardiac MyocytesPhysiologicalAnimal ModelMuscle Cells

Grant awards (51)

Step UP for STEM and Health Careers: An Intervention to Reduce STEM-related biases and improve high school STEM learning environments$863,909
R44 · FY2023 · HD
Defining novel mechanisms for human arrhythmia$809,572
R35 · FY2023 · HL · contact PI
Defining novel mechanisms for human arrhythmia$831,912
R35 · FY2022 · HL · contact PI
Eliminating Ischemic Spinal Cord Injury and Paralysis after Aortic Aneurysm Surgery$20,000
R13 · FY2022 · HL
Defining novel mechanisms for human arrhythmia$818,469
R35 · FY2021 · HL · contact PI
Defining novel mechanisms for human arrhythmia$844,242
R35 · FY2020 · HL · contact PI
Defining novel mechanisms for regulation of atrial INa and arrhythmias$748,613
R01 · FY2020 · HL · contact PI
Defining novel mechanisms for human arrhythmia$869,153
R35 · FY2019 · HL · contact PI
Defining novel mechanisms for regulation of atrial INa and arrhythmias$748,613
R01 · FY2019 · HL · contact PI
Training in Congenital and Acquired Heart Disease$28,281
T32 · FY2019 · HL
Defining novel mechanisms for human arrhythmia$890,490
R35 · FY2018 · HL · contact PI
Defining novel mechanisms for regulation of atrial INa and arrhythmias$746,887
R01 · FY2018 · HL · contact PI
Training in Congenital and Acquired Heart Disease$349,265
T32 · FY2018 · HL
Defining novel mechanisms for human arrhythmia$908,050
R35 · FY2017 · HL · contact PI
Defining novel mechanisms for regulation of atrial INa and arrhythmias$775,852
R01 · FY2017 · HL · contact PI
Training in Congenital and Acquired Heart Disease$333,406
T32 · FY2017 · HL
Training in Acquired and Congenital Heart Disease$10,392
T32 · FY2017 · HL
Training in Congenital and Acquired Heart Disease$2,592
T32 · FY2017 · HL
EHD proteins in cardiac membrane protein targeting and remodeling$540,191
R01 · FY2016 · HL · contact PI
Role of spectrin/ankyrin-G complex in myocyte signaling and cardiac excitability$295,611
R01 · FY2016 · HL · contact PI
Training in Congenital and Acquired Heart Disease$200,848
T32 · FY2016 · HL
EHD proteins in cardiac membrane protein targeting and remodeling$532,088
R01 · FY2015 · HL · contact PI
Role of ankyrin-B in human arrhythmia$375,531
R01 · FY2015 · HL · contact PI
Role of spectrin/ankyrin-G complex in myocyte signaling and cardiac excitability$349,946
R01 · FY2015 · HL · contact PI
Training in Congenital and Acquired Heart Disease$306,414
T32 · FY2015 · HL
EHD proteins in cardiac membrane protein targeting and remodeling$529,386
R01 · FY2014 · HL · contact PI
Role of ankyrin-B in human arrhythmia$373,625
R01 · FY2014 · HL · contact PI
Role of spectrin/ankyrin-G complex in myocyte signaling and cardiac excitability$348,803
R01 · FY2014 · HL · contact PI
EHD proteins in cardiac membrane protein targeting and remodeling$520,466
R01 · FY2013 · HL · contact PI
Role of ankyrin-B in human arrhythmia$362,950
R01 · FY2013 · HL · contact PI
Role of spectrin/ankyrin-G complex in myocyte signaling and cardiac excitability$339,433
R01 · FY2013 · HL · contact PI
Training in Congenital and Acquired Heart Disease$278,812
T32 · FY2013 · HL
Role of ankyrin-B in human arrhythmia$381,250
R01 · FY2012 · HL · contact PI
Role of spectrin/ankyrin-G complex in myocyte signaling and cardiac excitability$357,157
R01 · FY2012 · HL · contact PI
Training in Congenital & Acquired Heart Disease$293,118
T32 · FY2012 · HL
Role of ankyrin-B in human arrhythmia$381,250
R01 · FY2011 · HL · contact PI
Role of spectrin/ankyrin-G complex in myocyte signaling and cardiac excitability$297,161
R01 · FY2011 · HL · contact PI
Role of spectrin/ankyrin-G complex in myocyte signaling and cardiac excitability$78,881
R01 · FY2011 · HL · contact PI
Dysfunction in Ankyrin-based Pathways and Human Arrythmia$286,445
R01 · FY2010 · HL · contact PI
Molecular Mechanisms of Ankyrin-B-based Arrhythmia$152,831
R01 · FY2010 · HL · contact PI
Molecular Mechanisms of Ankyrin-B-based Arrhythmia$133,614
R01 · FY2010 · HL · contact PI
Molecular Mechanisms of Ankyrin-B-based Arrhythmia$286,445
R01 · FY2009 · HL · contact PI
Dysfunction in Ankyrin-based Pathways and Human Arrythmia$286,445
R01 · FY2009 · HL · contact PI
Dysfunction in Ankyrin-based Pathways and Human Arrythmia$141,647
R01 · FY2009 · HL · contact PI
Role of spectrin/ankyrin-G complex in myocyte signaling and cardiac excitability$85,888
R01 · FY2009 · HL · contact PI
Molecular Mechanisms of Ankyrin-B-based Arrhythmia$286,445
R01 · FY2008 · HL · contact PI
Dysfunction in Ankyrin-based Pathways and Human Arrythmia$286,445
R01 · FY2008 · HL · contact PI
Molecular Mechanisms of Ankyrin-B-based Arrhythmia$286,445
R01 · FY2007 · HL · contact PI
Dysfunction in Ankyrin-based Pathways and Human Arrythmia$286,445
R01 · FY2007 · HL · contact PI
Molecular Mechanisms of Ankyrin-B-based Arrhythmia$331,875
R01 · FY2006 · HL · contact PI
Dysfunction in Ankyrin-based Pathways and Human Arrythmia$329,833
R01 · FY2006 · HL · contact PI